Current Cancer Drug Targets
Volume 20, 11 Issues, 2020
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Ranking and Category
-
135th of 229 in
Oncology
Contents
Current Cancer Drug Targets, Volume 11 - Number 1
Molecular Pathogenesis of Philadelphia-Positive Chronic Myeloid Leukemia – is it all BCR-ABL?
, 11(1): 3 - 19H. Rumpold and G. Webersinke
DOI: 10.2174/156800911793743619
Current Treatment Concepts of CML
, 11(1): 31 - 43A. A. Leitner, A. Hochhaus and M. C. Muller
DOI: 10.2174/156800911793743637
Current Treatment Concepts of Philadelphia-Negative MPN
, 11(1): 44 - 55D. Wolf, J. Rudzki and G. Gastl
DOI: 10.2174/156800911793743592
Immunotherapy for Myeloproliferative Neoplasms (MPN)
, 11(1): 72 - 84Susanne Hofmann, Anna Babiak and Jochen Greiner
DOI: 10.2174/156800911793743682
Cancer Vaccines in Phase II/III Clinical Trials: State of the Art and Future Perspectives
, 11(1): 85 - 102S. Cecco, E. Muraro, E. Giacomin, D. Martorelli, R. Lazzarini, P. Baldo and R. Dolcetti
DOI: 10.2174/156800911793743664
Chronic Vaccination with a Therapeutic EGF-Based Cancer Vaccine: A Review of Patients Receiving Long Lasting Treatment
, 11(1): 103 - 110G. Gonzalez, T. Crombet and A. Lage
DOI: 10.2174/156800911793743583
High Therapeutic Potential for Systemic Delivery of a Liposomeconjugated Herpes Simplex Virus
, 11(1): 111 - 122T. Shikano, H. Kasuya, T. T. Sahin, N. Nomura, A. Kanzaki, M. Misawa, Y. Nishikawa, T. Shirota, S. Yamada, T. Fujii, H. Sugimoto, N. Kanazumi, S. Nomoto, S. Takeda and A. Nakao
DOI: 10.2174/156800911793743673
Human Equilibrative Nucleoside Transporter 1 (hENT1) Levels Predict Response to Gemcitabine in Patients With Biliary Tract Cancer (BTC)
, 11(1): 123 - 129D. Santini, G. Schiavon, B. Vincenzi, C. E. Cass, E. Vasile, A. D. Manazza, V. Catalano, G. G. Baldi, R. Lai, S. Rizzo, A. Giacobino, L. Chiusa, M. Caraglia, A. Russo, J. Mackey, A. Falcone and G. Tonini
DOI: 10.2174/156800911793743600
  |
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.75
Advertisement
Webmaster Contact: info@benthamscience.net